# Ophthalmological Adverse Events of Tralokinumab in AD

> **NCT05682976** · — · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 100 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05682976
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-14
- **Primary completion:** 2025-05-20
- **Final completion:** 2026-02-20
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05682976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05682976, "Ophthalmological Adverse Events of Tralokinumab in AD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05682976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*